2 weeks Ago By Defense World Staff
Bath & Body Works ( NYSE:BBWI – Free Report ) had its price target hoisted by Deutsche Bank Aktiengesellschaft from $51.00 to $52.00 in a report released on Tuesday, Benzinga reports.
The firm currently has a buy rating on the stock. Other research analysts have also recently issued research reports about the stock. Raymond James lowered their price target on shares of Bath & Body Works from $51.
00 to $42.00 and set an “outperform” rating on the stock in a research report on Thursday, August 29th. BMO Capital Markets reissued an “outperform” rating and issued a $50.
00 price target (down previously from $52.00) on shares of Bath & Body Works in a research note on Thursday, August 29th. JPMorgan Chase & Co.
lifted their price target on shares of Bath & Body Works from $35.00 to $39.00 and gave the company a “neutral” rating in a research report on Tuesday.
Robert W. Baird decreased their price objective on Bath & Body Works from $54.00 to $45.
00 and set an “outperform” rating on the stock in a report on Thursday, August 29th. Finally, Evercore ISI cut their target price on Bath & Body Works from $45.00 to $35.
00 and set an “in-line” rating for the company in a research note on Wednesday, August 28th. One investment analyst has rated the stock with a sell rating, six have assigned a hold rating and nine have assigned a buy rating to the company. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $41.
88. Read Our Latest Report on Bath & Body Works Bath & Body Works Price Performance Bath & Body Works ( NYSE:BBWI – Get Free Report ) last released its quarterly earnings data on Wednesday, August 28th. The company reported $0.
37 earnings per share for the quarter, topping analysts’ consensus estimates of $0.35 by $0.02.
Bath & Body Works had a negative return on equity of 41.94% and a net margin of 12.69%.
The company had revenue of $1.53 billion for the quarter, compared to analyst estimates of $1.54 billion.
On average, equities research analysts expect that Bath & Body Works will post 3.18 EPS for the current year. Bath & Body Works Announces Dividend The firm also recently disclosed a quarterly dividend, which will be paid on Friday, December 6th.
Stockholders of record on Friday, November 22nd will be paid a $0.20 dividend. This represents a $0.
80 annualized dividend and a dividend yield of 2.27%. The ex-dividend date of this dividend is Friday, November 22nd.
Bath & Body Works’s payout ratio is 19.37%. Insider Buying and Selling In related news, CEO Gina Boswell acquired 6,000 shares of the firm’s stock in a transaction dated Wednesday, October 9th.
The stock was acquired at an average price of $29.64 per share, for a total transaction of $177,840.00.
Following the purchase, the chief executive officer now owns 242,987 shares of the company’s stock, valued at $7,202,134.68. This represents a 2.
53 % increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink . 0.
27% of the stock is owned by insiders. Hedge Funds Weigh In On Bath & Body Works Several large investors have recently bought and sold shares of the business. California State Teachers Retirement System lifted its position in shares of Bath & Body Works by 1.
4% during the 1st quarter. California State Teachers Retirement System now owns 345,749 shares of the company’s stock worth $17,294,000 after buying an additional 4,695 shares during the last quarter. Tidal Investments LLC raised its stake in Bath & Body Works by 223.
9% during the 1st quarter. Tidal Investments LLC now owns 19,398 shares of the company’s stock worth $970,000 after acquiring an additional 13,410 shares in the last quarter. Atria Investments Inc purchased a new stake in Bath & Body Works in the first quarter valued at $1,058,000.
Northwest Bank & Trust Co boosted its stake in Bath & Body Works by 2.5% in the first quarter. Northwest Bank & Trust Co now owns 13,094 shares of the company’s stock valued at $655,000 after acquiring an additional 315 shares in the last quarter.
Finally, DekaBank Deutsche Girozentrale grew its holdings in shares of Bath & Body Works by 1.0% during the first quarter. DekaBank Deutsche Girozentrale now owns 31,797 shares of the company’s stock worth $1,560,000 after purchasing an additional 322 shares during the last quarter.
Hedge funds and other institutional investors own 95.14% of the company’s stock. About Bath & Body Works ( Get Free Report ) Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products.
It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements. See Also Five stocks we like better than Bath & Body Works How to Use High Beta Stocks to Maximize Your Investing Profits Cerence Up 155% in 2 Days: SoundHound AI’s Fierce Competitor Asset Allocation: The Key to a Successful Portfolio. Are You Paying Attention to Yours? Why Warren Buffett Is Selling: A Look at His Latest Market Moves 3 REITs to Buy and Hold for the Long Term Why Amazon Shares May Never Trade Below $200 Again Receive News & Ratings for Bath & Body Works Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bath & Body Works and related companies with MarketBeat.
com's FREE daily email newsletter ..
